Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Limongelli

Showing results (451-460 of 485) with videos related to

Pageof 49
Sort By:
European Heart Journal|April 9, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impactFrancesco Cappelli, Carlo Fumagalli, Marco Luigetti, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 10, 2015
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fractionDomenico Scrutinio, Piergiuseppe Agostoni, Loreto Gesualdo, et al.
Cardiovascular Ultrasound|January 20, 2017
Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart diseaseEugenio Picano, Quirino Ciampi, Rodolfo Citro, et al.
Heart (British Cardiac Society)|February 11, 2026
Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current eraMaryam Azar, Anna Apostolo, Elisabetta Salvioni, et al.
Frontiers in Cardiovascular Medicine|July 18, 2024
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter studyGiulia Grilli, Elisabetta Salvioni, Federica Moscucci, et al.
ESC Heart Failure|February 5, 2018
Mineralocorticoid receptor antagonists for heart failure: a real-life observational studyNoemi Bruno, Gianfranco Sinagra, Stefania Paolillo, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
ESC Heart Failure|September 25, 2024
The chronic heart failure evolutions: Different fates and routesPiergiuseppe Agostoni, Mattia Chiesa, Elisabetta Salvioni, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplantAlessia Argirò, Federica Colio, Manuel Garofalo, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 2, 2025
NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromesAdalena Tsatsopoulou, Dominic Jr Abrams, Aris Anastasakis, et al.
Pageof 49

Showing results (451-460 of 485) with videos related to

Sort By:
Pageof 49
European Heart Journal|April 9, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impactFrancesco Cappelli, Carlo Fumagalli, Marco Luigetti, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 10, 2015
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fractionDomenico Scrutinio, Piergiuseppe Agostoni, Loreto Gesualdo, et al.
Cardiovascular Ultrasound|January 20, 2017
Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart diseaseEugenio Picano, Quirino Ciampi, Rodolfo Citro, et al.
Heart (British Cardiac Society)|February 11, 2026
Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current eraMaryam Azar, Anna Apostolo, Elisabetta Salvioni, et al.
Frontiers in Cardiovascular Medicine|July 18, 2024
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter studyGiulia Grilli, Elisabetta Salvioni, Federica Moscucci, et al.
ESC Heart Failure|February 5, 2018
Mineralocorticoid receptor antagonists for heart failure: a real-life observational studyNoemi Bruno, Gianfranco Sinagra, Stefania Paolillo, et al.
European Journal of Heart Failure|November 29, 2025
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidisAldostefano Porcari, Paolo Milani, Simone Longhi, et al.
ESC Heart Failure|September 25, 2024
The chronic heart failure evolutions: Different fates and routesPiergiuseppe Agostoni, Mattia Chiesa, Elisabetta Salvioni, et al.
Revista Espanola De Cardiologia (English Ed.)|June 23, 2026
Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplantAlessia Argirò, Federica Colio, Manuel Garofalo, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 2, 2025
NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromesAdalena Tsatsopoulou, Dominic Jr Abrams, Aris Anastasakis, et al.
Pageof 49